Primary non-small-cell lung cancer: Determining the suitability of the patient and tumor for resection

Current Opinion in Pulmonary Medicine

Volumn 6, Issue 4, 2000, Pages 391-395

  Leonard, Colm T ^a   Whyte, Richard I ^a   Lillington, Glen A ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCINTISCANNING; CANCER STAGING; CANCER SURGERY; HEART FUNCTION; HUMAN; LUNG FUNCTION; LUNG NON SMALL CELL CANCER; PATIENT SELECTION; REVIEW; SURGICAL RISK; TUMOR BIOPSY;

EID: 0033914074     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-200007000-00023     Document Type: Review

References (37)

1. 1 Landis SH, Murray T, Bolden S, Wingo PA: Cancer statistics, 1998. CA Cancer J Clin 1998, 48:6-29.
2. 2 Mountain CF: Revisions in the International System for Staging Lung Cancer. Chest 1997, 111:1710-1717.
3. 3 Leong SS, Rocha Lima CM, Sherman CA, Green MR: The 1997 international staging system for non-small cell lung cancer: have all the issues been addressed? Chest 1999, 115:242-248. Further refinements are still possible.
4. 4 Mountain CF: Value of the new TNM staging system for lung cancer. Chest 1989, 96(Suppl 1):47S-49S.
5. 5 Al-Kattan K, Sepsas E, Townsend ER, Fountain SW: Factors affecting long term survival following resection for lung cancer. Thorax 1996, 51:1266-1269.
6. 6 Kadri MA, Dussek JE: Survival and prognosis following resection of primary non small cell bronchogenic carcinoma. Eur J Cardiothorac Surg 1991, 5:132-136.
7. 7 American Thoracic Society/European Respiratory Society: Pre-treatment evaluation of non-small-cell lung cancer. Am J Respir Crit Care Med 1997, 156:320-332.
8. 8 McKenna RJ, Libshitz HI, Mountain CE, McMurtrey MJ: Roentgenographic evaluation of mediastinal nodes for preoperative assessment in lung cancer. Chest 1985, 88:206-210.
9. 9 Dwamena BA, Sormad SS, Angobaldo JO, Wahl RL: Metastases from non-small cell lung cancer. Mediastinal staging in the 1990s: meta-analytic comparison of PET and CT. Radiology 1999, 213:530-536. The newest study.
10. 10 Dillemans B, Deneffe G, Verschakelen J, Decramer M: Value of computed tomography and mediastinoscopy in preoperative evaluation of mediastinal nodes in non-small cell lung cancer. Eur J Cardiothorac Surg 1994, 8:37-42.
11. 11 Luke MP, Pearson F, Todd TRJ, et al.: Prospective evaluation of mediastinoscopy for assessment of carcinoma of the lung. J Thorac Cardiovasc Surg 1986, 91:53-56.
12. 12 The Canadian Lung Oncology Group: Investigation for mediastinal disease in patients with apparently operable lung cancer. Ann Thorac Surg 1995, 60:1387-1389.
13. 13 Hammoud ZT, Anderson RC, Meyers BF, et al.: The current role of mediastinoscopy in the evaluation of thoracic disease. J Thorac Cardiovasc Surg 1999;118:894-899. Great study based on over 2000 cases.
14. 14 Harrow EM, Wang KP: The staging of lung cancer by bronchoscopic transbroncnial needle aspiration. Chest Surg Clin North Am 1996, 6:223-235.
15. 15 Sarinas PSA, Chitkara RK, Buadu EO, et al.: Usefulness of positron emission tomography imaging in the management of lung cancer. Curr Opin Pulm Med 1999, 5:201-207. Up-to-date and comprehensive, but does not include discussion on distant metastases.
16. 16 Saunders CA, Dussek JE, O'Doherty MJ, Maisey MN: Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer. Ann Thorac Surg 1999, 67:790-797.
17. 17 Scott WJ, Shepherd J, Gambhir SS: Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: a decision analysis. Ann Thorac Surg 1998, 66:1876-1885.
18. 18 Silvestri GA, Littenberg B, Colice GL: The clinical evaluation for detecting metastatic lung cancer: a meta-analysis. Am J Respir Crit Care Med 1995, 152:225-230.
19. 19 Hillers TK, Sauve MD, Guyatt GH: Analysis of published studies on the detection of extrathoracic metastases in patients presumed to have operable non-small cell lung cancer. Thorax 1994, 49:14-19.
20. 20 Smetana GW: Preoperative pulmonary evaluation. N Engl J Med 1999, 340:937-944.
21. 21 Mohr DN, Lavender RC: Preoperative pulmonary evaluation: identifying patients at increased risk for complications. Postgrad Med 1996, 100:241-256.
22. 22 De Perrot M, Licker M, Reymond MA, et al.: Influence of age on operative mortality and long-term survival after lung resection for bronchogenic carcinoma. Eur Respir J 1999, 14:419-422.
23. 23 Warner MA, Offord KP, Warner ME, et al.: Role of preoperative cessation of smoking and other factors in postoperative pulmonary complications: a blinded prospective study of coronary artery bypass patients. Mayo Clin Proc 1989, 64:609-616.
24. 24 Bluman LG, Mosca L, Newman N, Simon DG: Preoperative smoking habits and postoperative pulmonary complications. Chest 1998, 113:883-889.
25. 25 Lillington GA, Sachs DPL: Preoperative smoking reduction: all or nothing at all? Chest 1998, 111:856-858.
26. 26 Kearney DJ, Lee TH, Reilly JJ, et al.: Assessment of operative risk in patients undergoing lung resection: importance of predicted pulmonary function. Chest 1994, 105:753-759.
27. 27 Bolliger CT, Jordan P, Solèr M, et al.: Exercise capacity as a predictor of post-operative complications in lung resection candidates. Am J Respir Crit Care Med 1995, 151:1472-1480.
28. 28 Reilly JJ Jr: Evidence-based preoperative evaluation of candidates for thoracotomy. Chest (Suppl) 1999, 116:474S-476S. A succinct and practical recent review.
29. 29 Markos J, Mullan B, Hillman DR, et al.: Preoperative assessment as a predictor of mortality and morbidity after lung resection. Am Rev Respir Dis 1989, 139:902-910.
30. 30 Pierce RJ, Copland JM, et al: Preoperative risk evaluation for lung cancer resection: predicted postoperative product as a predictor of surgical mortality. Am J Respir Crit Care Med 1994, 150:947-955.
31. 31 Filaire M, Bedu M, Naamee A, et al.: Prediction of hypoxemia and mechanical ventilation after lung resection for cancer. Ann Thorac Surg 1999, 67:1460-1465.
32. 32 Wang J, Olak J, Ferguson MK: Diffusing capacity predicts operative mortality but not long-term survival after resection for lung cancer. J Thorac Cardiovasc Surg 1999, 117:581-587.
33. 33 Wyser C, Stulz P, Soler M, et al.: Prospective evaluation of an algorithm for the functional assessment of lung resection candidates. Am J Respir Crit Care Med 1999, 159:1450-1456. This algorithm is comprehensive and well validated.
34. 34 Bourasma M, Presberg KW, Chammas JH, et al.: Early and late morbidity in patients undergoing pulmonary resection with low diffusing capacity. Ann Thorac Surg 1996, 62:968-975.
35. 35 Cerfolio, RJ, Allen MS, Trastek VF, et al.: Lung resection in patients with compromised pulmonary function. Ann Thorac Surg 1996, 62:348-351.
36. 36 Pate P, Tenholder MF, Griffin JP, et al.: Preoperative assessment of the high-risk patient for lung resection. Ann Thorac Surg 1996, 61:494-500.
37. 37 Carretta A, Zannini P, Puglisi A, et al.: Improvement of pulmonary function after lobectomy for non-small cell lung cancer in emphysematous patients. Eur J Cardiothoracic Surg 1999, 15:602-607. There have been several reports of this type indicating that if the pulmonary function is improved by lung volume reduction surgery, resection of a concurrent malignant nodule may be feasible in candidates otherwise considered unfit for resection.